These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26958338)

  • 21. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
    Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
    J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-life safety of 5-grass pollen tablet in 5-to-9-year-old children with allergic rhinoconjunctivitis.
    Gerstlauer M; Szepfalusi Z; Golden D; Geng B; de Blic J
    Ann Allergy Asthma Immunol; 2019 Jul; 123(1):70-80. PubMed ID: 31009701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of grass pollen allergy: focus on a standardized grass allergen extract - Grazax®.
    Calderón M; Brandt T
    Ther Clin Risk Manag; 2008 Dec; 4(6):1255-60. PubMed ID: 19337432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases.
    Nolte H; Maloney J
    Allergol Int; 2018 Jul; 67(3):301-308. PubMed ID: 29759659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Cost-Minimisation Analysis Comparing Sublingual Immunotherapy to Subcutaneous Immunotherapy for the Treatment of House Dust Mite Allergy in a Swedish Setting.
    Björstad Å; Cardell LO; Hahn-Pedersen J; Svärd M
    Clin Drug Investig; 2017 Jun; 37(6):541-549. PubMed ID: 28326466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of house dust mite sublingual immunotherapy standardized quality tablet in children allergic to house dust mites.
    Maloney J; Prenner BM; Bernstein DI; Lu S; Gawchik S; Berman G; Kaur A; Li Z; Nolte H
    Ann Allergy Asthma Immunol; 2016 Jan; 116(1):59-65. PubMed ID: 26553448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
    Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
    Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax
    Sidenius K; Arvidsson P; Indbryn R; Emanuelsson CA
    Pulm Ther; 2021 Jun; 7(1):221-236. PubMed ID: 33772732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.
    Maloney J; Berman G; Gagnon R; Bernstein DI; Nelson HS; Kleine-Tebbe J; Kaur A; Li Q; Nolte H
    J Allergy Clin Immunol Pract; 2016; 4(2):301-9.e2. PubMed ID: 26755098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets.
    Nolte H; Casale TB; Lockey RF; Fogh BS; Kaur A; Lu S; Nelson HS
    J Allergy Clin Immunol Pract; 2017; 5(1):84-89.e3. PubMed ID: 27838323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice.
    Bernstein DI; Bardelas JA; Svanholm Fogh B; Kaur A; Li Z; Nolte H
    Postgrad Med; 2017 Aug; 129(6):590-597. PubMed ID: 28326906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet.
    Nelson H; Lehmann L; Blaiss MS
    Curr Med Res Opin; 2012 Jun; 28(6):1043-51. PubMed ID: 22502864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter, randomized, parallel-group trial assessing compliance, tolerability, safety, and efficacy to treatment with grass allergy tablets in 261 patients with grass pollen rhinoconjunctivitis.
    Alesina R; Milani M; Pecora S
    J Allergy (Cairo); 2012; 2012():673502. PubMed ID: 22131999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet.
    Nolte H; Bernstein DI; Sussman GL; Svanholm Fogh B; Lu S; Husøy B; Nelson HS
    J Allergy Clin Immunol Pract; 2018; 6(6):2081-2086.e1. PubMed ID: 29432959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of the standardized quality tree sublingual immunotherapy tablet: Pooled safety analysis of clinical trials.
    Biedermann T; Couroux P; Greve TM; Mäkelä M
    Allergy; 2021 Dec; 76(12):3733-3742. PubMed ID: 33905129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual Immunotherapy with a Five-Grass Pollen Tablet in Adult Patients with Allergic Rhinitis: An Open, Prospective, Noninterventional, Multicenter Study.
    Pfaar O; Richter HG; Klimek L; Sieber J; Hadler M; Karagiannis E
    Biomed Res Int; 2015; 2015():584291. PubMed ID: 26351635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.
    Dranitsaris G; Ellis AK
    J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis.
    Ellis AK; Mack DP; Gagnon R; Hammerby E; Gosain S
    Allergy Asthma Clin Immunol; 2023 Jan; 19(1):7. PubMed ID: 36653868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
    Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
    J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.